307 related articles for article (PubMed ID: 3860869)
1. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869
[TBL] [Abstract][Full Text] [Related]
2. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
St Clair WH
Carcinogenesis; 1991 May; 12(5):935-7. PubMed ID: 2029760
[TBL] [Abstract][Full Text] [Related]
3. Pyrene acts as a cocarcinogen with the carcinogens benzo[a]pyrene, beta-propiolactone and radiation in the induction of malignant transformation in cultured mouse fibroblasts; soybean extract containing the Bowman-Birk inhibitor acts as an anticarcinogen.
Baturay N; Kennedy AR
Cell Biol Toxicol; 1986 Mar; 2(1):21-32. PubMed ID: 3267443
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of radiation-induced transformation of C3H/10T1/2 cells by chymotrypsin inhibitor 1 from potatoes.
Billings PC; St Clair W; Ryan CA; Kennedy AR
Carcinogenesis; 1987 Jun; 8(6):809-12. PubMed ID: 3608078
[TBL] [Abstract][Full Text] [Related]
5. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
Yavelow J; Caggana M; Beck KA
Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
[TBL] [Abstract][Full Text] [Related]
6. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
[TBL] [Abstract][Full Text] [Related]
7. Studies on soybean trypsin inhibitors. XIII. Preparation and characterization of active fragments from Bowman-Birk proteinase inhibitor.
Odani S; Ikenaka T
J Biochem; 1978 Mar; 83(3):747-53. PubMed ID: 25270
[TBL] [Abstract][Full Text] [Related]
8. Bowman-Birk inhibitor concentrate reduces colon inflammation in mice with dextran sulfate sodium-induced ulcerative colitis.
Ware JH; Wan XS; Newberne P; Kennedy AR
Dig Dis Sci; 1999 May; 44(5):986-90. PubMed ID: 10235608
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a Bowman-Birk inhibitor active towards trypsin but not chymotrypsin in Lupinus albus seeds.
Scarafoni A; Consonni A; Galbusera V; Negri A; Tedeschi G; Rasmussen P; Magni C; Duranti M
Phytochemistry; 2008 Jun; 69(9):1820-5. PubMed ID: 18474386
[TBL] [Abstract][Full Text] [Related]
10. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans.
Birk Y
Int J Pept Protein Res; 1985 Feb; 25(2):113-31. PubMed ID: 3886572
[TBL] [Abstract][Full Text] [Related]
11. Fluorescent visualization of binding and internalization of the anticarcinogenic Bowman-Birk type protease inhibitors in transformed fibroblasts.
Yavelow J; Scott CB; Mayer TC
Cancer Res; 1987 Mar; 47(6):1602-7. PubMed ID: 3545449
[TBL] [Abstract][Full Text] [Related]
12. Studies on soybean trypsin inhibitors. IV. Change of the inhibitory activity of Bowman-Birk inhibitor upon replacements of the alpha-chymotrypsin reactive site serine residue by other amino acids.
Odani S; Ikenaka T
J Biochem; 1978 Jul; 84(1):1-9. PubMed ID: 690093
[No Abstract] [Full Text] [Related]
13. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
Weder JK; Hinkers SC
J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory properties of nonapeptide loop structures related to reactive sites of soybean Bowman-Birk inhibitor.
Terada S; Sato K; Kato T; Izumiya N
FEBS Lett; 1978 Jun; 90(1):89-92. PubMed ID: 658446
[No Abstract] [Full Text] [Related]
15. Structure-function relationships of proteinase inhibitors from soybean (Bowman-Birk) and lima bean. Modification by N-acetylimidazole.
Kay E
J Biol Chem; 1979 Aug; 254(16):7648-50. PubMed ID: 468777
[No Abstract] [Full Text] [Related]
16. Effect of a trypsin inhibitor from soybeans (Bowman-Birk) on the secretory activity of the human pancreas.
Liener IE; Goodale RL; Deshmukh A; Satterberg TL; Ward G; DiPietro CM; Bankey PE; Borner JW
Gastroenterology; 1988 Feb; 94(2):419-27. PubMed ID: 2446949
[TBL] [Abstract][Full Text] [Related]
17. Studies on soybean trypsin inhibitors. XI. Complete amino acid sequence of a soybean trypsin-chymotrypsin-elastase inhibitor, C-II.
Odani S; Ikenaka T
J Biochem; 1977 Dec; 82(6):1523-31. PubMed ID: 599141
[TBL] [Abstract][Full Text] [Related]
18. Proteases, protease inhibitors and radiation carcinogenesis.
Kennedy AR
Int J Radiat Biol; 2023; 99(6):882-890. PubMed ID: 34325613
[TBL] [Abstract][Full Text] [Related]
19. Anti-chymotrypsin and anti-elastase activities of a synthetic bicyclic fragment containing a chymotrypsin-reactive site of soybean Bowman-Birk inhibitor.
Ando S; Yasutake A; Waki M; Nishino N; Kato T; Izumiya N
Biochim Biophys Acta; 1987 Dec; 916(3):527-31. PubMed ID: 3689809
[TBL] [Abstract][Full Text] [Related]
20. Protease inhibitor suppression of colon and anal gland carcinogenesis induced by dimethylhydrazine.
Billings PC; Newberne PM; Kennedy AR
Carcinogenesis; 1990 Jul; 11(7):1083-6. PubMed ID: 2372868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
